Deal Ends Today·Save 35% annual plan
GLP-1 receptor agonistReviewed for 2026 plan year

Does Anthem Cover Ozempic?

The verdict

Conditional on most plans

Anthem covers Ozempic for type 2 diabetes with prior authorization through its CarelonRx PBM — covered across commercial, Medicare Advantage, and Medicaid. It is not covered for off-label weight-loss use under any Anthem line of business. This is the structural inverse of Anthem's Wegovy coverage: Wegovy requires an employer anti-obesity benefit opt-in; Ozempic for T2D is covered broadly without employer opt-in.

MedicareConditional
CommercialConditional
See the difference

Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Anthem using your member ID.

Reviewed for 2026
Checked against the active plan year
Sourced from formularies
Anthem drug lists + CMS guidance
Updated as rules change
Coverage and prior-auth criteria shift often
Verify before you decide
Informational only — not insurance advice

Key facts

  • Ozempic is FDA-approved for type 2 diabetes and cardiovascular risk reduction in T2D — not for weight loss. Anthem's CarelonRx covers it for the approved T2D indication with prior authorization.

    FDA drug labeling (semaglutide injection); CarelonRx formulary

  • Anthem covers Wegovy for weight loss only when the employer opts in to the anti-obesity benefit via CarelonRx, with a 5% weight-loss renewal requirement — a separate coverage track from the T2D Ozempic benefit.

    CarelonRx/Anthem commercial formulary documentation

  • The IRA Maximum Fair Price for semaglutide under Medicare is $274 per 30-day supply, effective January 1, 2027, representing a 71% discount off the CY2024 list price.

    CMS, IRA Drug Price Negotiation Program, 2024

Plan types

Medicare vs. commercial coverage

Whether Anthem covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.

Medicare

Part D & Advantage plans

Conditional

Medicare Advantage: Ozempic is covered for type 2 diabetes with prior authorization via CarelonRx. PA requires a documented T2D diagnosis and evidence of metformin step-therapy (or documented intolerance/contraindication). Cost-share depends on plan tier and design; the 2026 Part D $2,100 out-of-pocket cap limits annual Medicare beneficiary exposure. The IRA Maximum Fair Price for semaglutide (Ozempic/Rybelsus/Wegovy) is $274 per 30-day supply, effective January 1, 2027. Medicare Advantage and Medicaid enrollees cannot use the NovoCare $25 savings card. Ozempic is not covered for weight loss on any Anthem Medicare plan — off-label weight-loss use is statutorily excluded from Medicare Part D.

Commercial / Employer

Group & marketplace plans

Conditional

Commercial/Employer: Anthem covers Ozempic for type 2 diabetes with prior authorization via CarelonRx on both preferred and non-preferred brand tiers (tier varies by specific Anthem regional plan). Metformin step-therapy is standard; some Anthem plans require an additional oral agent trial. Not covered for off-label weight loss regardless of employer benefit design — this distinguishes Ozempic from Wegovy, which requires an employer anti-obesity benefit opt-in even when covered. Commercially insured T2D patients may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150/28-day supply) — not available to Medicare Advantage or Medicaid enrollees. ACA/Individual: covered for T2D with PA; not covered for weight loss. Medicaid: covered across Anthem Medicaid managed-care states with PA and nominal cost-share. Not covered for off-label weight loss on any Anthem Medicaid plan.

Prior authorization

The 3 boxes you must tick to get approved

Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.

Requirements you meet0 / 3

Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.

What you'll pay

Your cost, three ways

What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.

No coverage

Paying cash

~$1,028/month (Novo Nordisk published pricing, ~$1,027.51 for the 0.25/0.5 mg pen). NovoCare self-pay: ~$199/month intro (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).

List price with no coverage — before any manufacturer savings card.

PA approved

With coverage

Commercial/Employer: tier-based cost-share via CarelonRx; preferred brand tier carries lower cost-share than non-preferred. Verify your specific plan's tier on Anthem's drug lookup tool. Medicare Advantage: cost-share per plan design; $2,100 OOP cap 2026; IRA Maximum Fair Price $274/30-day effective January 1, 2027. Medicaid: nominal $0–$4 typical.

Typical monthly copay once prior authorization is approved.

Lowest cost

Bridge program

NovoCare Ozempic Savings Card: commercially insured T2D patients pay as little as $25 per fill (max $150 per 28-day supply). Not available to Medicare Advantage, Medicaid, VA, DoD, or TRICARE beneficiaries. Verify eligibility at NovoCare.com.

Reduced copay through the assistance program, where eligible.

All figures are estimates — verify exact cost-share on Anthem's drug lookup tool or by calling CarelonRx member services. Tier placement varies across Anthem's many regional commercial plans.

Do it yourself

Check YOUR exact coverage in 3 steps

General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.

  1. 1

    Use Anthem's drug lookup tool to confirm tier and PA requirements

    Log in to your Anthem member account or visit anthem.com and use the drug-lookup tool to confirm Ozempic is on your specific plan's formulary, its tier (preferred vs. non-preferred brand varies by regional plan), and any prior-authorization or step-therapy requirements via CarelonRx.

  2. 2

    Have your prescriber submit the prior-authorization through CarelonRx

    The PA submission requires: a documented T2D diagnosis (ICD-10 E11.x), evidence of metformin use or a documented reason you cannot take it, and — on some Anthem plans — documentation of an additional oral antidiabetic agent trial. The clinical indication must be type 2 diabetes, not weight management.

  3. 3

    Confirm the NovoCare savings card eligibility if you are commercially insured

    If you have an Anthem commercial or employer-sponsored plan and a confirmed T2D diagnosis, visit NovoCare.com to enroll in the Ozempic Savings Card, which may reduce your out-of-pocket cost to as little as $25 per fill (max $150/28-day supply). This card is not available to Anthem Medicare Advantage or Medicaid enrollees.

If it's denied

Options if Anthem won't cover Ozempic

A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.

Rybelsus (oral semaglutide)

Oral semaglutide for type 2 diabetes, covered via CarelonRx on Anthem formularies. Also subject to the IRA Maximum Fair Price of $274/30-day for Medicare patients effective January 1, 2027. Verify tier on Anthem's drug lookup.

Jardiance (empagliflozin)

SGLT-2 inhibitor commonly used as step therapy before Ozempic PA approval. Often on a preferred tier with lower cost-share than Ozempic on Anthem CarelonRx formularies.

Wegovy (semaglutide 2.4 mg)

For weight loss specifically: Anthem covers Wegovy for weight management only when the employer purchases the anti-obesity benefit (via CarelonRx with a 5% weight-loss renewal requirement). This requires employer opt-in — Ozempic for T2D does not. Not the same drug as Ozempic for diabetes purposes.

Compounded semaglutide (weight-loss seekers only)

For patients seeking semaglutide for weight management who are denied under Anthem, compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the Curex offer section below for full disclaimers.

These options are listed for information only — your own clinician decides what is appropriate for you.

Frequently Asked Questions

No. Anthem does not cover Ozempic for weight loss under any line of business. Ozempic holds FDA approval for type 2 diabetes glycemic control and cardiovascular risk reduction in T2D patients with known heart disease — not for weight management. Off-label weight-loss use is not a covered CarelonRx indication. Anthem's anti-obesity drug benefit (for Wegovy) requires a separate employer opt-in, and even then it covers the on-label weight-loss drug — not Ozempic.

Yes. Anthem covers Ozempic for type 2 diabetes with prior authorization via CarelonRx across commercial, Medicare Advantage, and Medicaid lines. PA requires a documented T2D diagnosis and evidence of metformin step-therapy. Tier varies by plan — preferred brand on some Anthem formularies, non-preferred on others. Verify your specific plan's tier and copay on Anthem's drug lookup tool or by calling CarelonRx.

Anthem covers Ozempic for type 2 diabetes broadly without any employer opt-in requirement. Wegovy for weight loss, by contrast, requires the employer to have purchased Anthem's anti-obesity benefit via CarelonRx, with a 5% weight-loss renewal requirement. The same insurer applies opposite coverage logic: T2D indication broadly covered; weight-loss indication employer-gated. Both semaglutide products are different drugs for regulatory and coverage purposes.

Yes, if you have an Anthem commercial or employer-sponsored plan and a T2D diagnosis. The NovoCare Ozempic Savings Card may reduce your cost to as little as $25 per fill (max $150 per 28-day supply). However, it is not available to Anthem Medicare Advantage or Medicaid enrollees — federal anti-kickback rules exclude government program beneficiaries. Verify eligibility at NovoCare.com before assuming the card applies to your plan.

Anthem's CarelonRx PA for Ozempic requires a documented type 2 diabetes diagnosis (ICD-10 E11.x) and evidence of metformin step-therapy — or a documented reason metformin is contraindicated or not tolerated. Some Anthem plans require an additional oral antidiabetic agent trial. A1c thresholds vary by plan and are not confirmed in a single primary Anthem/CarelonRx document. Ask your prescriber to review your plan's specific PA criteria on Anthem's authorization portal before submitting.

The Curex GLP-1 program

Insurance won't cover Ozempic for weight loss — here's a path that doesn't need it

Anthem's anti-obesity drug benefit requires employer opt-in and covers Wegovy on-label — not Ozempic, which is off-label for weight loss and not covered under any Anthem plan. For patients who want semaglutide access for weight management without insurance, Curex offers compounded semaglutide from $49/mo at getcurex.com/cl/glp — no prior authorization required. Compounded semaglutide is not the same medication as Ozempic or Wegovy. Tirzepatide compounded is also available from $149/mo. Prescription required, subject to provider review.

Compounded semaglutide
from$49/mo
Weekly injection or oral tablet
Compounded tirzepatide
from$149/mo
Injection or oral tablet
  • Medication + free shipping
  • 24/7 provider access
  • Medical intake & prescription review
From $49/moNo insurance requiredNo prior auth
Build your personalized planPrescription required, subject to provider review.

Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Anthem before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

Weight care with Curex

Insurance won't cover Ozempic for weight loss — here's a path that doesn't need it

Build your personalized plan

Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.